JOINT JOURNEY

Johnson & Johnson Innovation – JJDC, Inc. (JJDC) is the strategic venture capital arm of Johnson & Johnson, focused on investing across the healthcare spectrum. Established in 1973, it is one of the longest-standing corporate venture firms, with a mission to drive transformative innovations that address critical healthcare needs. JJDC invests globally across sectors like biotechnology, pharmaceuticals, medical devices, health tech, and digital health, often aligning its investments with Johnson & Johnson's core business areas. The firm has regional innovation centers in Boston, Menlo Park, London, and Shanghai, allowing it to stay close to emerging trends and collaborate with startups at various stages, from seed to later-stage rounds. JJDC's portfolio includes companies like Genmab, Vedanta Biosciences, and Bright Peak Therapeutics, reflecting its focus on breakthrough therapies and next-gen healthcare solutions. Additionally, JJDC leverages Johnson & Johnson’s extensive resources, providing not only capital but also strategic support, including R&D, regulatory guidance, and commercialization pathways. The investment approach of JJDC prioritizes long-term strategic value over immediate returns. This allows it to support ventures through the often lengthy development timelines typical of the healthcare industry, ultimately aiming to integrate successful innovations into Johnson & Johnson’s ecosystem. With a legacy of fostering groundbreaking medical technologies, JJDC remains committed to advancing patient care globally while continuing to evolve alongside the dynamic healthcare landscape.